• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ACOSOG Z0011 试验对亚洲患者外科实践的影响:韩国乳腺癌注册分析中乳腺癌腋窝手术的趋势。

Impact of the ACOSOG Z0011 trial on surgical practice in Asian patients: trends in axillary surgery for breast cancer from a Korean Breast Cancer Registry analysis.

机构信息

Department of Surgery, Hanyang University College of Medicine, 222, Wangsimni-ro, Seongdong-gu, 04764, Seoul, South Korea.

Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.

出版信息

World J Surg Oncol. 2022 Jun 13;20(1):198. doi: 10.1186/s12957-022-02673-4.

DOI:10.1186/s12957-022-02673-4
PMID:35698188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9195282/
Abstract

BACKGROUND

Since the publication of the Z0011 trial, practice-changing clinical guidelines for breast surgery have been developed. Although recent studies confirmed the feasibility of the Z0011 strategy in Asian populations, there has been no study on the trends of axillary surgery in Asian cohort. This study aimed to investigate the time trend of axillary surgery for breast cancer from a Korean Breast Cancer Registry to understand the impact of the Z0011 trial in Asian patients.

METHODS

We collected prospectively constructed data from the nationwide Korean Breast Cancer Registry (KBCR). We identified patients who underwent sentinel node biopsy followed by breast-conserving surgery from 2011 to 2018 and were found to have pathological stage T1-2N1-3M0 disease. Regression analyses were performed to compare the downward trend of axillary lymph node dissection (ALND) in Korean cohort with that previously reported in a Dutch cohort.

RESULTS

From KBCR data, 7478 patients met the inclusion criteria. The proportion of ALND significantly decreased from 2011 (76.6%) to 2018 (47.5%). Multivariate analysis revealed that earlier years at diagnosis, larger tumor size, and lymphatic invasion were associated with a higher odds ratio of performing ALND. Compared to the Dutch cohort, the downward trend of ALND in Korea was significantly more gradual (annual percent change: 37.2 vs. 5.8%, p < 0.001).

CONCLUSIONS

This study demonstrated a downward trend of ALND in Korean patients with breast cancer. However, the rate of decrease was significantly slower than that in the Dutch cohort.

摘要

背景

自 Z0011 试验发表以来,针对乳腺外科的临床实践指南发生了重大改变。尽管最近的研究证实了 Z0011 策略在亚洲人群中的可行性,但针对亚洲人群的腋窝手术趋势仍未有研究报道。本研究旨在通过韩国乳腺癌注册中心(KBCR)调查乳腺癌腋窝手术的时间趋势,以了解 Z0011 试验对亚洲患者的影响。

方法

我们从全国性的韩国乳腺癌注册中心(KBCR)中收集前瞻性构建的数据。我们从 2011 年至 2018 年期间,确定了接受前哨淋巴结活检和保乳手术后病理分期为 T1-2N1-3M0 的患者。我们通过回归分析比较韩国队列和荷兰队列中腋窝淋巴结清扫术(ALND)的下降趋势。

结果

从 KBCR 数据中,我们纳入了 7478 例符合条件的患者。ALND 的比例从 2011 年的 76.6%显著下降到 2018 年的 47.5%。多变量分析显示,诊断时的年份更早、肿瘤较大和淋巴管浸润与进行 ALND 的可能性更高有关。与荷兰队列相比,韩国 ALND 的下降趋势明显更为缓慢(年变化百分比:37.2% vs. 5.8%,p < 0.001)。

结论

本研究表明韩国乳腺癌患者的 ALND 呈下降趋势。然而,下降速度明显慢于荷兰队列。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/233b/9195282/b1b5d0b3a03c/12957_2022_2673_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/233b/9195282/b71153620cf1/12957_2022_2673_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/233b/9195282/292701f29534/12957_2022_2673_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/233b/9195282/b1b5d0b3a03c/12957_2022_2673_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/233b/9195282/b71153620cf1/12957_2022_2673_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/233b/9195282/292701f29534/12957_2022_2673_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/233b/9195282/b1b5d0b3a03c/12957_2022_2673_Fig3_HTML.jpg

相似文献

1
Impact of the ACOSOG Z0011 trial on surgical practice in Asian patients: trends in axillary surgery for breast cancer from a Korean Breast Cancer Registry analysis.ACOSOG Z0011 试验对亚洲患者外科实践的影响:韩国乳腺癌注册分析中乳腺癌腋窝手术的趋势。
World J Surg Oncol. 2022 Jun 13;20(1):198. doi: 10.1186/s12957-022-02673-4.
2
Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.Z0011时代前哨淋巴结阳性后省略腋窝淋巴结清扫术:大型前瞻性队列中对美国国立综合癌症网络(NCCN)和美国临床肿瘤学会(ASCO)临床指南及Z0011标准的遵循情况
Bull Cancer. 2022 Mar;109(3):268-279. doi: 10.1016/j.bulcan.2021.09.018. Epub 2021 Nov 24.
3
Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era.2011 年至 2015 年治疗的非远处转移性乳腺癌患者腋窝手术趋势:ACOSOG-Z0011 和 AMAROS 时代的荷兰基于人群的研究。
Ann Surg. 2018 Dec;268(6):1084-1090. doi: 10.1097/SLA.0000000000002440.
4
Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on clinical management of the axilla in older breast cancer patients: a SEER-medicare analysis.美国外科医师协会肿瘤学组(ACOSOG)Z0011 试验对老年乳腺癌患者腋窝临床管理的影响:一项 SEER-医疗保险分析。
Ann Surg Oncol. 2013 Dec;20(13):4145-52. doi: 10.1245/s10434-013-3193-1.
5
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.腋窝淋巴结清扫术与非腋窝淋巴结清扫术对浸润性乳腺癌伴前哨淋巴结转移女性患者10年总生存率的影响:美国外科医师学会肿瘤学组Z0011(联盟)随机临床试验
JAMA. 2017 Sep 12;318(10):918-926. doi: 10.1001/jama.2017.11470.
6
National Trend of Axillary Management in Clinical T3/T4 N0 Patients Having Breast Conserving Therapy.保乳治疗 T3/T4N0 期临床患者腋窝处理的全国趋势。
J Surg Res. 2020 Nov;255:361-370. doi: 10.1016/j.jss.2020.05.073. Epub 2020 Jun 27.
7
Changes in utilization of axillary dissection in women with invasive breast cancer and sentinel node metastasis after the ACOSOG Z0011 trial.ACOSOG Z0011 试验后浸润性乳腺癌伴前哨淋巴结转移女性腋窝清扫术利用的变化。
Breast J. 2021 Mar;27(3):216-221. doi: 10.1111/tbj.14191. Epub 2021 Feb 14.
8
Potential Impact of the Z0011 Trial on the Omission of Axillary Dissection: A Retrospective Cohort Study.Z0011试验对省略腋窝淋巴结清扫术的潜在影响:一项回顾性队列研究。
Rev Bras Ginecol Obstet. 2021 Apr;43(4):297-303. doi: 10.1055/s-0041-1725052. Epub 2021 Mar 30.
9
The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.在现代,早期浸润性乳腺癌的手术腋窝管理和辅助放疗状况。
Clin Breast Cancer. 2018 Aug;18(4):e477-e493. doi: 10.1016/j.clbc.2017.09.001. Epub 2017 Sep 19.
10
Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort.回顾性验证 ACOSOG Z0011 试验在大型亚洲 Z0011 合格队列中的结果。
Breast Cancer Res Treat. 2019 May;175(1):203-215. doi: 10.1007/s10549-019-05157-4. Epub 2019 Feb 4.

引用本文的文献

1
Clinical impact of the Z0011 trial on axillary surgical management in Australia and New Zealand from the BreastSurgANZ Quality Audit.来自澳大利亚和新西兰乳腺外科医师协会质量审计的Z0011试验对腋窝手术管理的临床影响。
ANZ J Surg. 2025 Mar;95(3):503-511. doi: 10.1111/ans.19404. Epub 2025 Jan 28.
2
Breast Cancer Statistics in Korea, 2021.2021年韩国乳腺癌统计数据
J Breast Cancer. 2024 Dec;27(6):351-361. doi: 10.4048/jbc.2024.0213. Epub 2024 Oct 31.
3
Axillary Surgery for Breast Cancer in 2024.2024年乳腺癌腋窝手术

本文引用的文献

1
Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study.ACOSOG Z0011 标准在中国乳腺癌患者中的应用:一项前瞻性研究。
World J Surg Oncol. 2021 Apr 20;19(1):128. doi: 10.1186/s12957-021-02242-1.
2
Loco-regional recurrence trend and prognosis in young women with breast cancer according to molecular subtypes: analysis of 1099 cases.根据分子亚型分析1099例年轻女性乳腺癌患者的局部区域复发趋势及预后
World J Surg Oncol. 2021 Apr 13;19(1):113. doi: 10.1186/s12957-021-02214-5.
3
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017.
Cancers (Basel). 2024 Apr 23;16(9):1623. doi: 10.3390/cancers16091623.
4
Changes in lymph node surgery in breast cancer and preoperative drug prescription analysis for postoperative pain management: A retrospective, cross-sectional study.乳腺癌淋巴结手术变化及术后疼痛管理术前药物处方分析:一项回顾性、横断面研究。
PLoS One. 2024 Apr 4;19(4):e0298270. doi: 10.1371/journal.pone.0298270. eCollection 2024.
5
Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer.T3-4c 期乳腺癌女性患者前哨淋巴结活检与腋窝淋巴结清扫的生存比较。
Oncologist. 2023 Aug 3;28(8):e591-e599. doi: 10.1093/oncolo/oyad038.
韩国癌症统计数据:2017 年发病率、死亡率、生存率和患病率。
Cancer Res Treat. 2020 Apr;52(2):335-350. doi: 10.4143/crt.2020.206. Epub 2020 Mar 16.
4
Cancer treatment and survivorship statistics, 2019.2019 年癌症治疗与生存统计
CA Cancer J Clin. 2019 Sep;69(5):363-385. doi: 10.3322/caac.21565. Epub 2019 Jun 11.
5
Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice.欧洲早期乳腺癌腋窝淋巴结清扫术的趋势:证据对实践的影响。
Breast. 2019 Jun;45:89-96. doi: 10.1016/j.breast.2019.03.002. Epub 2019 Mar 11.
6
Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort.回顾性验证 ACOSOG Z0011 试验在大型亚洲 Z0011 合格队列中的结果。
Breast Cancer Res Treat. 2019 May;175(1):203-215. doi: 10.1007/s10549-019-05157-4. Epub 2019 Feb 4.
7
Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer.外科医生对早期乳腺癌腋窝清扫术的态度。
JAMA Oncol. 2018 Nov 1;4(11):1511-1516. doi: 10.1001/jamaoncol.2018.1908.
8
A prospective feasibility study applying the ACOSOG Z0011 criteria to Japanese patients with early breast cancer undergoing breast-conserving surgery.应用 ACOSOG Z0011 标准对接受保乳手术的日本早期乳腺癌患者进行前瞻性可行性研究。
Int J Clin Oncol. 2018 Oct;23(5):860-866. doi: 10.1007/s10147-018-1297-0. Epub 2018 May 22.
9
Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era.2011 年至 2015 年治疗的非远处转移性乳腺癌患者腋窝手术趋势:ACOSOG-Z0011 和 AMAROS 时代的荷兰基于人群的研究。
Ann Surg. 2018 Dec;268(6):1084-1090. doi: 10.1097/SLA.0000000000002440.
10
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.早期乳腺癌患者前哨淋巴结活检:美国临床肿瘤学会临床实践指南更新。
J Clin Oncol. 2017 Feb 10;35(5):561-564. doi: 10.1200/JCO.2016.71.0947. Epub 2016 Dec 12.